v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net revenue $ 17,175 $ 11,013 $ 33,883 $ 21,145
Cost of goods sold 3,734 2,620 7,456 4,961
Gross profit 13,441 8,393 26,427 16,184
Selling, general and administrative expenses (includes $862, $887, $2,101 and $1,736 to related parties, respectively) 20,086 12,849 38,294 23,351
Research and development expenses (includes $2,645, $1,060, $5,710 and $2,295 to related parties, respectively) 3,391 1,406 7,145 2,989
Operating loss (10,036) (5,862) (19,012) (10,156)
Other (income) expense        
Interest (income) expense, net (673) 216 (1,109) 583
Change in fair value of Series E purchase option 0 11,719 0 11,719
Loss on extinguishment of debt 589 0 589 0
Other expense, net 201 1,399 40 1,400
Total other (income) expense 117 13,334 (480) 13,702
Loss before income tax expense (10,153) (19,196) (18,532) (23,858)
Income tax expense 0 0 0 0
Net loss (10,153) (19,196) (18,532) (23,858)
Other comprehensive loss, net        
Unrealized gain (loss) on marketable securities (40) 1 (221) (115)
Total other comprehensive gain (loss), net (40) 1 (221) (115)
Comprehensive loss $ (10,193) $ (19,195) $ (18,753) $ (23,973)
Net loss per share attributed to common stock – basic and diluted:        
Net loss per share - basic (in dollars per share) $ (0.49) $ (165.53) $ (0.90) $ (232.13)
Net loss per share - diluted (in dollars per share) $ (0.49) $ (165.53) $ (0.90) $ (232.13)
Weighted average shares outstanding        
Weighted average common shares outstanding – basic (in shares) 20,735,694 115,965 20,694,593 102,775
Weighted average common shares outstanding – diluted (in shares) 20,735,694 115,965 20,694,593 102,775